JALPA PATEL: Open Payments
NPI 1194025411 · CLARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 51 payments from 19 companies in 2025. Trend: 2023 $711 · 2024 $755 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $178 |
| PFIZER INC. | 9 | $152 |
| Regeneron Healthcare Solutions, Inc. | 5 | $83 |
| UCB, Inc. | 3 | $56 |
| GENZYME CORPORATION | 2 | $38 |
| Incyte Corporation | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $26 |
| LEO Pharma Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: CIBINQO, NEMLUVIO, Bimzelx, DUPIXENT, LIBTAYO, LITFULO, OPZELURA, ANZUPGO.
Industry payments across NJ — which companies pay providers there.
